| Genomic landscape of lung adenocarcinoma in East Asians J Chen, H Yang, ASM Teo, LB Amer, FG Sherbaf, CQ Tan, JJS Alvarez, ... Nature genetics 52 (2), 177-186, 2020 | 319 | 2020 |
| Profilin negatively regulates formin-mediated actin assembly to modulate PAMP-triggered plant immunity H Sun, Z Qiao, KP Chua, A Tursic, X Liu, YG Gao, Y Mu, X Hou, Y Miao Current Biology 28 (12), 1882-1895. e7, 2018 | 47 | 2018 |
| Integrative profiling of T790M-negative EGFR-mutated NSCLC reveals pervasive lineage transition and therapeutic opportunities KP Chua, YHF Teng, AC Tan, A Takano, JJS Alvarez, R Nahar, N Rohatgi, ... Clinical Cancer Research 27 (21), 5939-5950, 2021 | 23 | 2021 |
| Dynamic phenotypic heterogeneity and the evolution of multiple RNA subtypes in hepatocellular carcinoma: the PLANET study W Zhai, H Lai, NA Kaya, J Chen, H Yang, B Lu, JQ Lim, S Ma, SC Chew, ... National science review 9 (3), nwab192, 2022 | 19 | 2022 |
| Characterization and visualization of tandem repeats at genome scale E Dolzhenko, A English, H Dashnow, G De Sena Brandine, T Mokveld, ... Nature Biotechnology, 1-9, 2024 | 10 | 2024 |
| P1. 17-07 Neoadjuvant gefitinib in resectable early stage EGFR mutant non-small cell lung cancer (NSCLC): a window-of-opportunity study A Tan, KP Chua, A Takano, J Alvarez, BH Ong, T Koh, ZW Aung, A Jain, ... Journal of Thoracic Oncology 14 (10), S609-S610, 2019 | 9 | 2019 |
| Replica exchange molecular dynamics simulation of cross‐fibrillation of IAPP and PrP106‐126 KP Chua, LY Chew, Y Mu Proteins: Structure, Function, and Bioinformatics 84 (8), 1134-1146, 2016 | 8 | 2016 |
| Somatic variant workflow with HiFi sequencing provides new insights in highly challenging cancer cases KP Chua, I McLaughlin, O Hofmann, KP Stewart, P Baybayan, ... Cancer Research 84 (6_Supplement), 2934-2934, 2024 | | 2024 |
| P59. 08 THOR: Multi-Ethnic, Open Access Thoracic Cancer Genomics Resource J Alvarez, KP Chua, NL Sim, M Abedi, J Chen, A Tan, G Lai, A Takano, ... Journal of Thoracic Oncology 16 (3), S540, 2021 | | 2021 |
| P69. 05 Molecular and Cellular Heterogeneity Underpin Treatment Response Across a Spectrum of EGFR-Mutant Non-Small Cell Lung Cancer J Yuan, E Lim, SM Ma, KP Chua, YF Lee, MJ Lim, XH Yeo, C Phua, ... Journal of Thoracic Oncology 16 (3), S562, 2021 | | 2021 |
| MA13. 08 Genomic and Transcriptomic Features of Distinct Resistance Trajectories in EGFR Mutant Non-Small Cell Lung Cancer (NSCLC) A Tan, KP Chua, Y Teng, A Takano, J Alvarez, R Nahar, N Rohatgi, G Lai, ... Journal of Thoracic Oncology 16 (3), S184, 2021 | | 2021 |
| P2. 13-21 MET Addiction Can be Circumvented Through EGFR Inhibition Via AXL in MET-Amplified Primary Resistant EGFR-Mutant NSCLCX. L Kwang, D Lau, A Liew, Y Ju, E Lim, G Lai, R Nahar, Y Teng, KP Chua, ... Journal of Thoracic Oncology 13 (10), S806, 2018 | | 2018 |
| Mechanistic insights into proteins association through molecular dynamics KP Chua | | 2017 |
